CPR Pharma Services Pty Ltd, Australia   Report issue

For profit Phase 1
Founded: Adelaide Australia (2008)

Organization Overview

First Clinical Trial
2010
NCT01222949
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

CPR Pharma Services Pty Ltd, Australia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 1)

Hepatitis B (Phase 1)

Hepatitis B, Chronic (Phase 1)

Inflammation (Phase 1)

Malaria, Falciparum (Phase 1)

Pneumonia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 9
  • # of Trial APIs: 13